Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA-matching

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapy for many malignant and non-malignant hematological disorders [1,2]. Although matched-related donor (MRD) or matched-unrelated donor (MUD) are considered the ideal sources of hematopoietic stem cells, many patients lack timely access to a suitable matched-donor, especially in the context of aggressive diseases.

Source: Biology of Blood and Marrow Transplantation - January 27, 2020 Category: Hematology Authors: Chiara Oltolini, Raffaella Greco, Laura Galli, Daniela Clerici, Francesca Lorentino, Elisabetta Xue, Maria Teresa Lupo Stanghellini, Fabio Giglio, Lina Uhr, Marco Ripa, Paolo Scarpellini, Massimo Bernardi, Consuelo Corti, Jacopo Peccatori, Antonella Casta Source Type: research